Morphle Labs

Morphle Labs

Private
Bangalore, KarnatakaHealthcare & Life Scienceshttps://morphlelabs.com

Last Round

Series A

Nov 25, 2025

Total Funding Raised

$5.23M

Momentum Score

25 /100

Company Overview

Morphle Labs is a medical device company that provides AI-powered robotic microscopes and digital pathology scanners. Founded in 2017 and based in Bengaluru, India, the company develops hardware and software to automate tissue processing and slide scanning for applications in pathology, particularly for cancer diagnostics. Their products, which include whole slide scanners and AI-driven workflows, are designed to improve image quality, increase scanning speed, and facilitate telepathology for pathology labs, cancer hospitals, and research institutes. The company was part of Y Combinator's Winter 2020 batch.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Medical Imaging, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

digital pathologywhole slide scannerrobotic microscopetelepathologypathology AIcomputational pathologyAI diagnosticsmicroscopy automationpathology softwaredigital slide scannercancer diagnosticspathology workflowIHC scoringcell countingmicrotomy automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Morphle Labs Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Morphle Labs Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series ANov 25, 2025
SeedMar 17, 2020
GrantDec 15, 2019

Key People

Founding team and executive leadership

Rohit Hiwale

Founder CEO

Founding Team

Sunnel Daniel

Chief Operating Officer, Vice President Of Sales

Executive Team

Morphle Labs Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 5, 2025

    Claims market leadership in India with global customer growth.

  • Nov 25, 2025

    $5M round completed.

Morphle Labs Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Morphle Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Morphle Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersBangalore, Karnataka
Employee Range96
Year Founded2017
Last FundingNov 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.